ipoGoogle News
148 IPOs Are Waiting: Can India’s Markets Absorb the Rush? | TMB Decode - The Economic Times
148 IPOs Are Waiting: Can India’s Markets Absorb the Rush? | TMB Decode The Economic Times
GN1 hour ago
Read More//
VEEDA_CLINICAL_RESEARCH_ · Health Care · Veeda Clinical Research Limited Unlisted / Pre-IPO Share Price
As of 25 Sept 2026, the Veeda Clinical Research Limited unlisted share price is ₹428 per share. Veeda Clinical Research Limited is an unlisted / pre-IPO company — not listed on NSE or BSE. ISIN: INE01HQ01026.
▼ ₹132 (−23.57%) over all time
Key figures for Veeda Clinical Research Limited
Veeda Clinical Research Limited is an Indian contract research organization providing clinical trial services including bioequivalence, early-phase, late-phase and pharmacovigilance. Headquartered in Ahmedabad with multiple facilities, Veeda serves global and domestic pharmaceutical companies and has conducted thousands of studies across therapeutic areas. The company emphasizes quality systems, volunteer safety, data integrity and regulatory compliance, with accreditations/inspections from multiple agencies.
Veeda Clinical Research Limited shares are unlisted, so they are bought off-market through a SEBI-registered intermediary rather than on the NSE or BSE. With Safal Capital the process is simple:
No. Veeda Clinical Research Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE and there is no live “Veeda Clinical Research Limitedshare price NSE”. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Veeda Clinical Research Limited has not announced a confirmed IPO date. Investors buy unlisted shares ahead of a potential listing for pre-IPO upside, but a listing is never guaranteed and timelines can change. The ISIN for Veeda Clinical Research Limited is INE01HQ01026. Contact our desk for the latest status and a live quote before you invest.
Veeda Clinical Research Limited is an unlisted company operating in the Health Care sector (Clinical Research Organization (CRO)). Veeda Clinical Research Limited is an Indian contract research organization providing clinical trial services including bioequivalence, early-phase, late-phase and pharmacovigilance. Headquartered in Ahmedabad with multiple facilities, Veeda serves global and domestic pharmaceutical companies and ha…
The current unlisted market price is ₹423.72 per share with a market capitalisation of approximately ₹2815 crore. The company is currently unlisted and investors should factor in illiquidity risk and longer holding horizons. Investors are advised to review the full financial data and consult an advisor before investing.
Leave your name and mobile, our unlisted shares desk will call you back with live pricing and availability.
Latest source-linked updates that may be relevant to this company.
148 IPOs Are Waiting: Can India’s Markets Absorb the Rush? | TMB Decode The Economic Times
Indian stock market will double in five years, says Motilal Oswal’s Raamdeo Agrawal Financial Times
Sensex, Nifty 50 prediction today: Stock market outlook for 25 Sept 2026 | GIFT Nifty, Nikkei, Taiwan cues to watch Livemint
As of 25 Sept 2026, the Veeda Clinical Research Limited unlisted (pre-IPO) share price is ₹428 per share on Safal Capital. Unlisted share prices move with demand, supply and deal size, so contact our desk for a live, deal-specific quote before you transact.
You buy Veeda Clinical Research Limited unlisted shares off-market through a SEBI-registered intermediary. With Safal Capital: (1) share your requirement and quantity, (2) we confirm the live price and availability, (3) you complete KYC, (4) transfer funds, and (5) the shares are credited to your demat account, usually within T+1 to T+2 working days.
No. Veeda Clinical Research Limited is currently an unlisted / pre-IPO company, so its shares are not traded on the NSE or BSE. They are transacted off-market between buyers and sellers through SEBI-registered intermediaries such as Safal Capital.
Veeda Clinical Research Limited has not announced a confirmed IPO date. Unlisted shares are often bought before a potential listing in the hope of pre-IPO gains, but a listing is never guaranteed and timelines can change. Speak to our advisors for the latest status on Veeda Clinical Research Limited.
The ISIN for Veeda Clinical Research Limited unlisted shares is INE01HQ01026. You will need this ISIN when the shares are credited to your demat account.
Veeda Clinical Research Limited unlisted shares have a face value of ₹2 and a typical minimum lot of 100 shares. Minimum quantities can vary with availability and deal size — our desk will confirm the current lot before you invest.
Unlisted share prices are not set by an exchange. The Veeda Clinical Research Limited price reflects recent off-market deals, buyer/seller demand, the company's financials and expectations around a future IPO. Because it is over-the-counter, always confirm a live quote before transacting.
Unlisted shares like Veeda Clinical Research Limited can offer pre-IPO upside but carry higher risk and lower liquidity than listed stocks, and there is no guaranteed exit. Invest only after reviewing the company's fundamentals and your risk profile — Safal Capital's SEBI-registered advisors can help you assess Veeda Clinical Research Limited.